A recent study observed that TNF-α inhibitors led to significant improvements in clinical symptoms and a rapid and substantial decrease in the number of osteoclast precursors in the peripheral blood of psoriasis patients with erosive arthritis [180]. The gene discussed is TNF; the disease is psoriasis.